{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:02:16Z","timestamp":1761919336417},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,6,4]],"date-time":"2010-06-04T00:00:00Z","timestamp":1275609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s00415-010-5606-4","type":"journal-article","created":{"date-parts":[[2010,6,3]],"date-time":"2010-06-03T17:39:55Z","timestamp":1275586795000},"page":"1703-1707","source":"Crossref","is-referenced-by-count":12,"title":["Influence of apolipoprotein E plasma levels and tobacco smoking on the induction of neutralising antibodies to interferon-beta"],"prefix":"10.1007","volume":"257","author":[{"given":"Armando","family":"Sena","sequence":"first","affiliation":[]},{"given":"Klaus","family":"Bendtzen","sequence":"additional","affiliation":[]},{"given":"Maria J.","family":"Cascais","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Pedrosa","sequence":"additional","affiliation":[]},{"given":"V\u00e9ronique","family":"Ferret-Sena","sequence":"additional","affiliation":[]},{"given":"Elisa","family":"Campos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,6,4]]},"reference":[{"key":"5606_CR1","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00415-006-0486-3","volume":"254","author":"HP Hartung","year":"2007","unstructured":"Hartung HP, Polman C, Bertolotto A et al (2007) Neutralising antibodies to interferon \u03b2 in multiple sclerosis: expert panel report. J Neurol 254:827\u2013837","journal-title":"J Neurol"},{"key":"5606_CR2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-0-387-75841-1_7","volume-title":"Biotechnology: pharmaceutical aspects vol VIII. Immunogenicity of biopharmaceuticals","author":"K Bendtzen","year":"2008","unstructured":"Bendtzen K, Kromminga A (2008) Immunogenicity of interferon-beta. In: van de Weert M, Moller EH (eds) Biotechnology: pharmaceutical aspects vol VIII. Immunogenicity of biopharmaceuticals. Springer, New York, pp 127\u2013136"},{"key":"5606_CR3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ajhg.2008.07.006","volume":"83","author":"S Hoffmann","year":"2008","unstructured":"Hoffmann S, Cepok S, Grummel V et al (2008) HLA-DRB1*0401 and HLA-DRB1 *0408 are strongly associated with the development of antibodies against interferon-\u03b2 therapy in multiple sclerosis. Am J Hum Genet 83:219\u2013227","journal-title":"Am J Hum Genet"},{"key":"5606_CR4","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1212\/01.wnl.0000327340.50284.8d","volume":"71","author":"F Gilli","year":"2008","unstructured":"Gilli F, Valentino P, Caldano M (2008) Expression and regulation of IFNalpha\/beta receptor in IFNbeta-treated patients with multiple sclerosis. Neurology 71:1940\u20131947","journal-title":"Neurology"},{"key":"5606_CR5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.1137221","volume":"316","author":"JC Lo","year":"2007","unstructured":"Lo JC, Wang Y, Tumanov AV et al (2007) Lymphotoxin alpha receptor-dependent control of lipid homeostasis. Science 316:285\u2013288","journal-title":"Science"},{"key":"5606_CR6","doi-asserted-by":"crossref","unstructured":"Getz SG, Reardon CA (2009) Apoprotein E as a lipid transport and signalling protein in the blood, liver, and artery wall. J Lipid Res S156\u2013S161","DOI":"10.1194\/jlr.R800058-JLR200"},{"key":"5606_CR7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1034\/j.1600-0404.2002.01334.x","volume":"106","author":"F Giubilei","year":"2002","unstructured":"Giubilei F, Antonini G, De Legges S et al (2002) Blood cholesterol and MRI activity in first episode suggestive of multiple sclerosis. Acta Neurol Scand 106:109\u2013112","journal-title":"Acta Neurol Scand"},{"key":"5606_CR8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/1352458508098371","volume":"15","author":"A Jamroz-Wisniewska","year":"2009","unstructured":"Jamroz-Wisniewska A, Beltowski J, Stelmasiak Z, Bartosik-Psujek H (2009) Paraoxonase 1 activity in different types of multiple sclerosis. Mult Scler 15:399\u2013402","journal-title":"Mult Scler"},{"key":"5606_CR9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","volume":"50","author":"WI McDonald","year":"2001","unstructured":"McDonald WI, Compston A, Edan G et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on diagnosis of multiple sclerosis. Ann Neurol 50:121\u2013127","journal-title":"Ann Neurol"},{"key":"5606_CR10","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444\u20131452","journal-title":"Neurology"},{"key":"5606_CR11","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.WNL.0000156155.19270.F8","volume":"64","author":"RH Roxburgh","year":"2005","unstructured":"Roxburgh RH, Seaman SR, Masterman T et al (2005) Multiple sclerosis severity score: using disability and disease duration to rate disease severity. Neurology 64:1144\u20131151","journal-title":"Neurology"},{"key":"5606_CR12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/ana.20740","volume":"59","author":"J Rio","year":"2006","unstructured":"Rio J, Nos C, Tintor\u00e9 M et al (2006) Defining the response to interferon-beta in relapsing-remitting multiple sclerosis patients. Ann Neurol 59:344\u2013352","journal-title":"Ann Neurol"},{"key":"5606_CR13","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0140-6736(03)14541-2","volume":"362","author":"PS Sorensen","year":"2003","unstructured":"Sorensen PS, Ross C, Clemmesen KM et al (2003) Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis. Lancet 362:1184\u20131191","journal-title":"Lancet"},{"key":"5606_CR14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499\u2013502","journal-title":"Clin Chem"},{"key":"5606_CR15","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1468-1331.2009.02603.x","volume":"l16","author":"A Sena","year":"2009","unstructured":"Sena A, Couderc Ferret-SenaV et al (2009) Apolipoprotein E polymorphism interacts with cigarette smoking in progression of multiple sclerosis. Eur J Neurol l16:832\u2013837","journal-title":"Eur J Neurol"},{"key":"5606_CR16","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1093\/brain\/awp228","volume":"132","author":"M Comabella","year":"2009","unstructured":"Comabella M, Lunemann JD, Rio J et al (2009) A type I interferon signature in monocytes associated with poor response to interferon-beta in multiple sclerosis. Brain 132:3353\u20133365","journal-title":"Brain"},{"key":"5606_CR17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0009-8981(91)90070-S","volume":"196","author":"J Carlsson","year":"1991","unstructured":"Carlsson J, Armstrong VW, Reiber H et al (1991) Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid. Clin Chem Acta 196:167\u2013176","journal-title":"Clin Chem Acta"},{"key":"5606_CR18","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1124\/jpet.106.103671","volume":"318","author":"L Feng-Qiao","year":"2006","unstructured":"Feng-Qiao L, Sempowski GD, McKenna SE et al (2006) Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in murine model of multiple sclerosis. J Pharmacol Exp Ther 318:956\u2013965","journal-title":"J Pharmacol Exp Ther"},{"key":"5606_CR19","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1194\/jlr.M800172-JLR200","volume":"49","author":"L Li","year":"2008","unstructured":"Li L, Thompson PA, Kitchens RL (2008) Infection induces a positive acute phase apolipoprotein E response from a negative acute phase gene: role of hepatic LDL receptors. J Lipid Res 49:1782\u20131793","journal-title":"J Lipid Res"},{"key":"5606_CR20","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1177\/1352458507076968","volume":"13","author":"N Garg","year":"2007","unstructured":"Garg N, Weinstock-Guttman B, Bhasi K, Locke J, Ramanathan M (2007) An association between autoreactive antibodies and anti-interferon-\u03b2 antibodies in multiple sclerosis. Mult Scler 13:895\u2013899","journal-title":"Mult Scler"},{"key":"5606_CR21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(04)16752-4","volume":"364","author":"A Sena","year":"2004","unstructured":"Sena A, Pedrosa R, Gra\u00e7a Morais M (2004) Statins for multiple sclerosis. Lancet 364:412","journal-title":"Lancet"},{"key":"5606_CR22","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nri803","volume":"2","author":"M Sapori","year":"2002","unstructured":"Sapori M (2002) Effects of cigarette smoke on the immune system. Nat Rev Immunol 2:372\u2013377","journal-title":"Nat Rev Immunol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-010-5606-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-010-5606-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-010-5606-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T10:28:59Z","timestamp":1591352939000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-010-5606-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,4]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["5606"],"URL":"https:\/\/doi.org\/10.1007\/s00415-010-5606-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,4]]}}}